Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NEE
|
James L Robo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 41,466 Added 10.69% |
$3,006,285
$72.5 p/Share
|
Sep 01
2020 |
BMY
|
Karen Murphy Santiago
SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 220 Reduced 2.62% |
$13,413
$60.97 p/Share
|
Sep 01
2020 |
BMY
|
Karen Murphy Santiago
SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 642 Added 7.11% |
-
|
Sep 01
2020 |
ADBE
|
Ann Lewnes
EVP, CMO, Corp Strategy & Dev |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 12.42% |
$2,598,700
$519.74 p/Share
|
Sep 01
2020 |
LLY
|
Michael B Mason
EVP & Pres., Lilly Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct | 2,735 Reduced 12.85% |
$405,847
$148.39 p/Share
|
Sep 01
2020 |
LLY
|
Michael B Mason
EVP & Pres., Lilly Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct | 6,244 Added 22.69% |
-
|
Sep 01
2020 |
GOOG
|
Ann Mather
Director |
SELL
Open market or private sale
|
Direct | 20 Reduced 1.74% |
$32,718
$1635.9 p/Share
|
Sep 01
2020 |
MICS
|
Bernardo Melo
Chief Revenue Officer |
BUY
Open market or private purchase
|
Direct | 25,000 Added 2.71% |
$7,250
$0.29 p/Share
|
Sep 01
2020 |
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 37,734 Added 0.32% |
$56,224
$1.49 p/Share
|
Sep 01
2020 |
CSSE
|
Greenhaven Road Investment Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,979 Reduced 0.24% |
$27,963
$14.13 p/Share
|
Sep 01
2020 |
CFFA
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,718 Reduced 0.44% |
$152,478
$10.36 p/Share
|
Sep 01
2020 |
EVBG
|
Elliot J. Mark
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 830 Reduced 7.02% |
$125,911
$151.7 p/Share
|
Sep 01
2020 |
EVBG
|
James Totton
EVP, Product Mgmt, Eng & Ops |
SELL
Open market or private sale
|
Direct | 1,351 Reduced 82.78% |
$204,055
$151.04 p/Share
|
Sep 01
2020 |
EVBG
|
Patrick Brickley
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,165 Added 48.06% |
$170,755
$33.06 p/Share
|
Sep 01
2020 |
EVBG
|
Patrick Brickley
EVP and CFO |
SELL
Open market or private sale
|
Direct | 3,541 Reduced 63.44% |
$534,974
$151.08 p/Share
|
Sep 01
2020 |
EVBG
|
Phillip E Huff
VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 441 Reduced 12.62% |
$65,537
$148.61 p/Share
|
Sep 01
2020 |
EVBG
|
Phillip E Huff
VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,275 Added 26.74% |
-
|
Sep 01
2020 |
EVBG
|
Imad Mouline
SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,887 Reduced 10.57% |
$436,283
$151.12 p/Share
|
Sep 01
2020 |
EVRI
|
Randy L Taylor
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 169 Reduced 0.18% |
$1,332
$7.88 p/Share
|
Sep 01
2020 |
EVRI
|
Randy L Taylor
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 695 Added 0.71% |
-
|
Sep 01
2020 |
EVRI
|
Michael D Rumbolz
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 1,065 Reduced 0.3% |
$8,392
$7.88 p/Share
|
Sep 01
2020 |
EVRI
|
Michael D Rumbolz
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 2,709 Added 0.76% |
-
|
Sep 01
2020 |
ENPH
|
Jeff Mc Neil
EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.83% |
$588,300
$78.44 p/Share
|
Sep 01
2020 |
SPLP
|
Douglas Woodworth
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,500 Added 16.93% |
-
|
Sep 01
2020 |
SPLP
|
Gordon A. Walker
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 50,000 Added 41.67% |
-
|
Sep 01
2020 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$4,139,850
$275.99 p/Share
|
Sep 01
2020 |
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Sep 01
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 6.95% |
$296,700
$59.34 p/Share
|
Sep 01
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
SELL
Bona fide gift
|
Indirect | 500 Reduced 0.05% |
-
|
Sep 01
2020 |
CRM
|
Parker Harris
Co-Founder and CTO, Slack |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 7.47% |
$1,378,600
$275.72 p/Share
|
Sep 01
2020 |
CRM
|
Amy E Weaver
President and CFO |
SELL
Bona fide gift
|
Direct | 11,000 Reduced 36.11% |
-
|
Sep 01
2020 |
XOMA
|
Bvf Partners L P
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 17,572 Added 1.01% |
$331,584
$18.87 p/Share
|
Sep 01
2020 |
CAR
|
Srs Investment Management, LLC |
BUY
Open market or private purchase
|
Indirect | 31,800 Added 0.18% |
$1,114,590
$35.05 p/Share
|
Sep 01
2020 |
UBER
|
Tony West |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.71% |
$67,240
$33.62 p/Share
|
Aug 31
2020 |
REGN
|
George L Sing
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.52% |
$6,124,299
$612.43 p/Share
|
Aug 31
2020 |
REGN
|
Joseph J Larosa
EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct | 4,672 Reduced 24.45% |
$2,873,466
$615.04 p/Share
|
Aug 31
2020 |
FFIN
|
Murray Hamilton Edwards |
BUY
Open market or private purchase
|
Indirect | 230 Added 0.0% |
$7,003
$30.45 p/Share
|
Aug 31
2020 |
BFST
|
James J. Buquet Iii
Director |
BUY
Open market or private purchase
|
Indirect | 75 Added 0.0% |
$1,133
$15.11 p/Share
|
Aug 31
2020 |
DTIL
|
Dario Scimeca
General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 3,156 Added 37.64% |
$15,117
$4.79 p/Share
|
Aug 31
2020 |
UTG
|
Thomas W Harmke |
BUY
Other acquisition or disposition
|
Direct | 1 Added 0.41% |
$32
$31.95 p/Share
|
Aug 31
2020 |
EXPE
|
Jonathan L Dolgen |
SELL
Open market or private sale
|
Direct | 2,016 Reduced 2.97% |
$199,745
$99.08 p/Share
|
Aug 31
2020 |
AMOT
|
Ashish Bendre
VP and Group President |
BUY
Open market or private purchase
|
Direct | 16 Added 0.05% |
$681
$42.59 p/Share
|
Aug 31
2020 |
TCRR
|
Garry E Menzel
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 1,132 Added 24.98% |
$11,433
$10.1 p/Share
|
Aug 31
2020 |
TCRR
|
Alfonso Quintas Cardama
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,118 Added 26.87% |
$11,292
$10.1 p/Share
|
Aug 31
2020 |
WAL
|
Timothy W Boothe
Chief Administration Officer |
BUY
Small Acquisition
|
Direct | 74 Added 0.15% |
$2,637
$35.64 p/Share
|
Aug 31
2020 |
WINRW
|
Jed Philip Kaplan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,875 Added 0.99% |
-
|
Aug 31
2020 |
WINRW
|
Roman Nehemiah Franklin
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 938 Added 1.51% |
-
|
Aug 31
2020 |
ODFL
|
Earl E Congdon
Chair Emeritus & Sr. Advisor |
SELL
Bona fide gift
|
Indirect | 292 Reduced 0.03% |
-
|
Aug 31
2020 |
MBIN
|
Michael F. Petrie
Chairman and CEO |
SELL
Bona fide gift
|
Direct | 24,700 Reduced 1.52% |
-
|
Aug 31
2020 |
MBIO
|
Manuel Md Litchman
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 1.0% |
$12,400
$2.48 p/Share
|
Aug 31
2020 |